Healthcare & Assistive
From da Vinci surgical systems to rehab exoskeletons and elder-care companions, robotics is reshaping healthcare. This section grades what works in the clinic vs the marketing.
Topics in Healthcare & Assistive
24 articles
A hardware-first assessment of the da Vinci, Hugo, and Versius surgical robot ecosystems, grading claims by deployment status, analyzing clinical workflows, and mapping India availability with landed cost estimates.
An evidence-based assessment of shipping rehab exoskeletons, grading ReWalk, Ekso Bionics, and Cyberdyne HAL by regulatory status, clinical outcomes, and procurement realities, with specific attention to India availability and landed cost estimates.
A grounded assessment of elder-care robotics, evaluating shipped hardware like ElliQ, Paro, and Lovot against pilot deployments and announcements. Covers technical specifications, deployment constraints, regulatory pathways, and realistic India availability with landed cost estimates.
Grounded assessment of shipping hospital AMRs, evaluating Aethon TUG and Diligent Moxi against manufacturer specifications, verified deployment data, and integration requirements. Covers safety standards, workflow impact, and India market availability with clearly flagged landed cost estimates.
A hardware-first assessment of the da Vinci, Hugo RAS, and Versius platforms, grading claims by shipping status, pilot deployments, and manufacturer announcements, with explicit notes on India availability and landed cost estimates.
A grounded assessment of the current state of rehabilitation exoskeletons, evaluating ReWalk, Ekso, and Cyberdyne HAL based on shipped units, clinical trials, and real-world deployment. Includes analysis of India’s import landscape, regulatory pathways, and approximate landed costs for clinicians and institutions.
An evidence-based assessment of ElliQ, Paro, and Lovot, graded by shipping status, pilot deployment data, and India availability. The analysis separates manufacturer claims from verified operational performance, outlines landed cost estimates for Indian buyers, and outlines the regulatory and logistical constraints facing assistive home companions in India.
A grounded evaluation of shipped hospital autonomous mobile robots, focusing on Aethon TUG and Diligent Robotics’ Moxi. We examine deployed hardware specifications, clinical integration workflows, safety certifications, and India market availability with landed cost estimates.
An evidence-based assessment of the surgical robotics landscape, graded by shipping hardware first, pilot deployments second, and announcements last. Covers da Vinci, Hugo, Versius, instrumentation economics, clinical validation pathways, and India availability with approximate landed cost estimates.
A grounded assessment of shipping rehab exoskeletons, grading claims by hardware delivery and clinical validation. Covers ReWalk, Ekso Bionics, and Cyberdyne HAL, with independent reporting on efficacy, manufacturing status, and India availability with landed cost estimates.
A grounded assessment of shipping elder-care companions like ElliQ, Paro, and Lovot, graded by hardware availability, pilot deployments, and India import realities.
A grounded assessment of autonomous mobile robots deployed in hospital logistics, graded by actual shipping hardware over pilots and announcements. Covers Aethon TUG, Diligent Robotics Moxi, navigation architecture, integration constraints, and India availability with landed cost estimates.
An evidence-based assessment of da Vinci, Versius, and Hugo RAS in the soft-tissue surgical robotics space. Claims are graded by deployed units, independent clinical evaluations, and regulatory status, with explicit notes on India availability, CDSCO pathways, and approximate landed pricing.
An evidence-graded review of commercial rehab exoskeletons, focusing on ReWalk, Ekso, and Cyberdyne HAL hardware status, independent clinical outcomes, and realistic India availability with landed cost estimates.
A grounded assessment of commercially available elder-care robots, graded by deployment status and hardware readiness. Covers ElliQ, Paro, Lovot, and the technical and regulatory realities of deploying assistive home companions in India and global markets.
A grounded evaluation of commercial hospital AMRs, prioritizing shipped hardware over pilot claims, with technical specifications, deployment realities, and India market availability.
A deployment-graded assessment of the da Vinci, Hugo, and Versius surgical robot platforms, covering architecture, clinical validation, India procurement pathways, and landed cost estimates for soft-tissue minimally invasive surgery.
A hardware-first assessment of commercial rehab exoskeletons, grading ReWalk, Ekso Bionics, and Cyberdyne HAL by deployed units, regulatory status, and independent clinical outcomes, with explicit notes on India availability and approximate landed pricing.
A grounded assessment of ElliQ, Paro, and Lovot, graded by deployment status, technical limitations, maintenance requirements, and landed costs in India. The article separates shipping hardware from pilot deployments, reviews manufacturer specifications, and outlines regulatory and import realities for assistive home companions.
A hardware-first assessment of autonomous mobile robots (AMRs) for hospital logistics, focusing on Aethon TUG and Moxi. The article grades deployment maturity, reviews clinical workflow integration, examines India market availability, and provides landed cost estimates based on manufacturer specifications and independent procurement data.
An evidence-based assessment of the da Vinci, Hugo, and Versius surgical robot platforms, graded by commercial deployment status, technical specifications, and India availability.
A grounded assessment of commercial rehab exoskeletons—ReWalk, Ekso Bionics, and Cyberdyne HAL—analyzed by shipped hardware, clinical outcomes, deployment logistics, and India market availability.
A grounded evaluation of ElliQ, Paro, Lovot, and assistive home companions. This article grades claims by shipping hardware, pilot deployments, and announcements, examines clinical and commercial deployment data, and maps India availability, import duties, and landed cost estimates.
A grounded assessment of hospital autonomous mobile robots, focusing on Aethon TUG and Diligent Moxi. This article grades claims by verified deployments, details technical integration and safety protocols, and outlines India availability and landed cost estimates.